IMPACT OF A MULTIFACETED EDUCATIONAL INTERVENTION ON ORAL ANTICOAGULATION (OAC) USE IN ATRIAL FIBRILLATION (AF) PATIENTS ACCORDING TO ASPIRIN USE AT BASELINE: INSIGHTS FROM IMPACT-AF TRIAL

Jie Jiang,Ying Xian,Hussein R. Al-Khalidi,Maria Cecilia Bahit,Renato D. Lopes,Dragos Vinereanu,Denis Xavier,He Pengkang,He WenSheng,Andrea O. Ciobanu,Deepak Kamanth,Kathleen Fox,Meena Rao,Sean D. Pokorney,Otavio Berwanger,Carlos Tajer,Pedro Gabriel Melo De Barros E Silva,Mayme L. Roettig,Yong Huo,Christopher B. Granger

IMPACT OF A MULTIFACETED EDUCATIONAL INTERVENTION ON ORAL ANTICOAGULATION (OAC) USE IN ATRIAL FIBRILLATION (AF) PATIENTS ACCORDING TO ASPIRIN USE AT BASELINE: INSIGHTS FROM IMPACT-AF TRIAL

2018

Despite being a Class III recommendations, aspirin is still commonly used for stroke prevention in AF. We assessed the differential impact of a multifaceted educational intervention on OAC use in AF patients according to aspirin use at baseline. This was a prespecified analysis of IMPACT-AF, a

Keywords:

Atrial fibrillation
Internal medicine
Cardiology
Stroke
Medicine
Aspirin
oral anticoagulation
stroke prevention
class iii
differential impact
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations